Halozyme Therapeutics Inc. Revenue

Revenue Gross Profit Operating Income EBITDA Net Income EPS Shares Outstanding

No data available.

Halozyme Therapeutics Inc. (HALO) — Frequently Asked Questions

Halozyme Therapeutics Inc. (HALO) is a publicly traded US company. Explore HALO's stock price, financial statements, earnings history, margins and key ratios below.

What is the HALO stock price?

HALO trades at $70.50 (-1.37% on the day).